Issue 2/2022
Content (9 Articles)
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice
- Dapagliflozin
- Current Opinion
Marc Evans, Angharad R. Morgan, Martin B. Whyte, Wasim Hanif, Stephen C. Bain, Philip A. Kalra, Sarah Davies, Umesh Dashora, Zaheer Yousef, Dipesh C. Patel, W. David Strain
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
- Open Access
- Rituximab
- Review Article
Jorge Rojas-Rivera, Fernando C. Fervenza, Alberto Ortiz
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy
- Chronic Lymphocytic Leukemia
- Review Article
Lindsey E. Roeker, Meghan Thompson, Anthony R. Mato
Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets
- Open Access
- Review Article
Deanna H. Dang, Kamran M. Riaz, Dimitrios Karamichos
Gastrointestinal Dysfunction in Parkinson’s Disease
- Constipation
- Review Article
Delaram Safarpour, Kaveh Sharzehi, Ronald F. Pfeiffer
Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis
- Open Access
- Brivaracetam
- Systematic Review
Simona Lattanzi, Eugen Trinka, Gaetano Zaccara, Pasquale Striano, Emilio Russo, Cinzia Del Giovane, Mauro Silvestrini, Francesco Brigo